NORTHWEST BIOTHERAPEUTICS INC Annual Share-based Payment Arrangement, Expense in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Northwest Biotherapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2011 to 2023.
  • Northwest Biotherapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $689K, a 57.5% decline year-over-year.
  • Northwest Biotherapeutics Inc Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $4.56M, a 15.5% decline year-over-year.
  • Northwest Biotherapeutics Inc annual Share-based Payment Arrangement, Expense for 2023 was $4.41M, a 64.2% decline from 2022.
  • Northwest Biotherapeutics Inc annual Share-based Payment Arrangement, Expense for 2022 was $12.3M, a 21% decline from 2021.
  • Northwest Biotherapeutics Inc annual Share-based Payment Arrangement, Expense for 2021 was $15.6M, a 70% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $4.41M -$7.89M -64.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-05
2022 $12.3M -$3.27M -21% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-05
2021 $15.6M -$36.4M -70% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-05
2020 $52M +$50.1M +2753% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
2019 $1.82M -$12.5M -87.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-03-01
2018 $14.3M +$13.7M +2415% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-16
2017 $568K Jan 1, 2017 Dec 31, 2017 10-K 2019-04-02
2015 $2M -$6.7M -77% Jan 1, 2015 Dec 31, 2015 10-K 2016-03-16
2014 $8.7M +$7.35M +544% Jan 1, 2014 Dec 31, 2014 10-K 2016-03-16
2013 $1.35M -$1.85M -57.9% Jan 1, 2013 Dec 31, 2013 10-K 2014-04-01
2012 $3.2M -$5.24M -62.1% Jan 1, 2012 Dec 31, 2012 10-K 2014-04-01
2011 $8.45M Jan 1, 2011 Dec 31, 2011 10-K 2013-04-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.